Evidence map›Paper›PMID 41910839›Full record

ArticleNeurochemical research2026

MitoQ Triggers Mitochondrial Collapse and Apoptotic Death in Glioblastoma Associated with KATP Channel Expression Changes.

Alp Karaaslan, Ceyhan Hacioglu

Abstract read
In one paragraph

Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alp KaraaslanDepartment of Neurosurgery, İstanbul Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital, İstanbul, Turkey.ORCID http://orcid.org/0000-0003-4213-0906
Ceyhan HaciogluDepartment of Medical Biochemistry, Faculty of Medicine, Düzce University, Düzce, Turkey. ceyhanhacioglu@duzce.edu.tr.ORCID http://orcid.org/0000-0002-0993-6118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor and remains refractory to current therapies due to its pronounced metabolic heterogeneity and mitochondrial adaptability. Ion channels, particularly ATP-sensitive-potassium (KATP) channels, have emerged as critical regulators of cellular energy sensing in cancer. This study evaluated the mitochondrial-targeted agent MitoQ in GBM and explored its potential association with KATP channels. In this study, the cytotoxic potential of MitoQ was systematically evaluated in three genetically distinct GBM cell lines. Cell viability was assessed using concentration-response analyses to identify differential sensitivity. Baseline expression of KATP-channel components (KCNJ11/Kir6.2, ABCC8/SUR1, and CCDC51) was quantified by qRT-PCR and Western blotting. Mechanistic analyses were subsequently performed in the most sensitive cell line and included mitochondrial ROS measurement (MitoSOX), confocal assessment of mitochondrial morphology, Seahorse XF-based bioenergetic profiling, ATP/ADP ratio quantification, analysis of autophagic flux via LC3-II/p62 turnover with bafilomycin-A1, and caspase-3/7-based apoptosis detection. U87 cells exhibited the lowest IC₅₀ for MitoQ and showed significantly higher baseline expression of KATP channel subunits compared to U251 and T98G cells. Acute MitoQ exposure (10 µM, 6 h) in U87 cells induced marked mitochondrial superoxide accumulation, extensive mitochondrial fragmentation, severe suppression of oxidative phosphorylation, and ATP depletion. These effects were associated with selective downregulation of Kir6.2 and the mitochondrial KATP-associated component CCDC51, impaired autophagic flux with p62 accumulation, and robust activation of executioner caspases. In conclusion, MitoQ may induce mitochondrial dysfunction in metabolically primed GBM cells, and cellular sensitivity appears to correlate with a distinct KATP channel expression signature.

Indexed as

ApoptosisBrain NeoplasmsGlioblastomaKATP ChannelsMitochondriaOrganophosphorus CompoundsUbiquinoneCell Line, TumorCell SurvivalHumansReactive Oxygen SpeciesKATP ChannelsmitoquinoneOrganophosphorus CompoundsReactive Oxygen SpeciesUbiquinoneATP-sensitive potassium (KATP) channelsGlioblastomaMitochondrial dysfunctionMitoquinone (MitoQ)

Identifiers

PMID41910839
PMCPMC13035687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.